カテゴリ： 世界, 医療/バイオ, Market Monitor Global

がん治療&検査装置のグローバル市場展望 2023年-2029年：がん検出、がん治療

■ 英語タイトル：Cancer Therapy and Testing Market, Global Outlook and Forecast 2023-2029

調査会社Market Monitor Global社が発行したリサーチレポート（データ管理コード：MMG23DC12280）■ 発行会社/調査会社：Market Monitor Global
■ 商品コード：MMG23DC12280
■ 発行日：2023年12月
■ 調査対象地域：グローバル、北米、アメリカ、ヨーロッパ、アジア、日本、中国、東南アジア、インド、南米、中東・アフリカなど
■ 産業分野：医療
■ ページ数：107
■ レポート言語：英語
■ レポート形式：PDF
■ 納品方式：Eメール（受注後2-3営業日）
■ 販売価格オプション（消費税別）
Single User（1名様閲覧用）USD3,250 ⇒換算￥494,000見積依頼/購入/質問フォーム
Multi User（20名様閲覧用）USD4,225 ⇒換算￥642,200見積依頼/購入/質問フォーム
Enterprise User（閲覧人数制限なし）USD4,875 ⇒換算￥741,000見積依頼/購入/質問フォーム
※販売価格オプションの説明はこちらで、ご購入に関する詳細案内はご利用ガイドでご確認いただけます。
※お支払金額は「換算金額（日本円）＋消費税＋配送料（Eメール納品は無料）」です。
※Eメールによる納品の場合、通常ご注文当日～2日以内に納品致します。
※レポート納品後、納品日＋5日以内に請求書を発行・送付致します。（請求書発行日より2ヶ月以内の銀行振込条件、カード払いも可能）
※Market Monitor Global社の概要及び新刊レポートはこちらでご確認いただけます。
★グローバルリサーチ資料[がん治療&検査装置のグローバル市場展望 2023年-2029年：がん検出、がん治療]についてメールでお問い合わせはこちら
*** レポート概要（サマリー）***

当調査レポートは次の情報を含め、世界のがん治療&検査装置市場規模と予測を収録しています。・世界のがん治療&検査装置市場：売上、2018年-2023年、2024年-2029年
・世界のがん治療&検査装置市場：販売量、2018年-2023年、2024年-2029年
・世界のトップ5企業、2022年

世界のがん治療&検査装置市場は2022年に000Mドルと評価され、予測期間中に000％のCAGRで2029年までに000Mドルに達すると予測されています。米国市場は2022年に000Mドルと推定されており、中国は2029年までに000Mドルに達すると予測されています。「がん検出」セグメントは今後6年間、000%のCAGRで2029年までに000Mドルに成長すると予測されています。

がん治療&検査装置のグローバル主要企業は、Invitae、 Foundation Medicine、 Guardant Health、 Illumina、 Sysmex、 Abingdon Health、 Sophia、 NanoEntek、 BGI、 Diagnosis、 Exact Sciences、 AstraZeneca、 Bayer AG、 Johnson & Johnson、 Pfizer Inc.などです。2022年にトップ5企業がグローバル売上シェアの約000%を占めています。

MARKET MONITOR GLOBAL（MMG）は、がん治療&検査装置のメーカー、サプライヤー、流通業者、および業界の専門家を調査しました。これには、販売量、売上、需要、価格変動、製品タイプ、最近の動向と計画、産業トレンド、成長要因、課題、阻害要因、潜在的なリスクなどが含まれます。

【セグメント別市場分析】

世界のがん治療&検査装置市場：タイプ別、2018年-2023年、2024年-2029年
世界のがん治療&検査装置市場：タイプ別市場シェア、2022年
・がん検出、がん治療

世界のがん治療&検査装置市場：用途別、2018年-2023年、2024年-2029年
世界のがん治療&検査装置市場：用途別市場シェア、2022年
・肺がん、直腸がん、乳がん、その他

世界のがん治療&検査装置市場：地域・国別、2018年-2023年、2024年-2029年
世界のがん治療&検査装置市場：地域別市場シェア、2022年
・北米：アメリカ、カナダ、メキシコ
・ヨーロッパ：ドイツ、フランス、イギリス、イタリア、ロシア
・アジア：中国、日本、韓国、東南アジア、インド
・南米：ブラジル、アルゼンチン
・中東・アフリカ：トルコ、イスラエル、サウジアラビア、UAE

【競合分析】

また、当レポートは主要な市場参加者の分析を提供します。
・主要企業におけるがん治療&検査装置のグローバル売上、2018年-2023年
・主要企業におけるがん治療&検査装置のグローバル売上シェア、2022年
・主要企業におけるがん治療&検査装置のグローバル販売量、2018年-2023年
・主要企業におけるがん治療&検査装置のグローバル販売量シェア、2022年

さらに、当レポートは主要企業のプロファイルを提示します。
Invitae、 Foundation Medicine、 Guardant Health、 Illumina、 Sysmex、 Abingdon Health、 Sophia、 NanoEntek、 BGI、 Diagnosis、 Exact Sciences、 AstraZeneca、 Bayer AG、 Johnson & Johnson、 Pfizer Inc.

*************************************************************

・調査・分析レポートの概要
がん治療&検査装置市場の定義
市場セグメント
世界のがん治療&検査装置市場概要
当レポートの特徴・ベネフィット
調査手法と情報源

・世界のがん治療&検査装置市場規模
世界のがん治療&検査装置市場規模：2022年 VS 2029年
世界のがん治療&検査装置市場規模と予測 2018年-2029年

・競争状況
グローバルトップ企業
売上ベースでのグローバルトップ企業
企業別グローバルでのがん治療&検査装置の売上
グローバルトップ3およびトップ5企業、2022年売上ベース
グローバル企業のがん治療&検査装置製品タイプ
グローバルにおけるティア1、ティア2、ティア3企業

・タイプ別市場分析
タイプ区分：がん検出、がん治療
がん治療&検査装置のタイプ別グローバル売上・予測

・用途別市場分析
用途区分：肺がん、直腸がん、乳がん、その他
がん治療&検査装置の用途別グローバル売上・予測

・地域別市場分析
地域別がん治療&検査装置市場規模 2022年と2029年
地域別がん治療&検査装置売上・予測
北米市場：アメリカ、カナダ、メキシコ
ヨーロッパ市場：ドイツ、フランス、イギリス、イタリア、ロシア
アジア市場：中国、日本、韓国、東南アジア、インド
南米市場：ブラジル、アルゼンチン
中東・アフリカ市場：トルコ、イスラエル、サウジアラビア、UAE

・主要企業のプロファイル（企業概要、事業概要、主要製品、売上、ニュースなど）
Invitae、 Foundation Medicine、 Guardant Health、 Illumina、 Sysmex、 Abingdon Health、 Sophia、 NanoEntek、 BGI、 Diagnosis、 Exact Sciences、 AstraZeneca、 Bayer AG、 Johnson & Johnson、 Pfizer Inc.
...

This research report provides a comprehensive analysis of the Cancer Therapy and Testing market, focusing on the current trends, market dynamics, and future prospects. The report explores the global Cancer Therapy and Testing market, including major regions such as North America, Europe, Asia-Pacific, and emerging markets. It also examines key factors driving the growth of Cancer Therapy and Testing, challenges faced by the industry, and potential opportunities for market players.
The global Cancer Therapy and Testing market has witnessed rapid growth in recent years, driven by increasing environmental concerns, government incentives, and advancements in technology. The Cancer Therapy and Testing market presents opportunities for various stakeholders, including Lung Cancer, Rectal Cancer. Collaboration between the private sector and governments can accelerate the development of supportive policies, research and development efforts, and investment in Cancer Therapy and Testing market. Additionally, the growing consumer demand present avenues for market expansion.
The global Cancer Therapy and Testing market was valued at US$ 660230 million in 2022 and is projected to reach US$ 1621170 million by 2029, at a CAGR of 13.8% during the forecast period. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
The cancer therapy and testing market has been witnessing significant growth over the years and is expected to continue expanding in the future. Several factors contribute to this market growth, including the increasing incidence of cancer globally, advancements in diagnostic technologies, personalized medicine approaches, and a growing emphasis on early detection and targeted therapies.
Key Features:
The research report on the Cancer Therapy and Testing market includes several key features to provide comprehensive insights and facilitate decision-making for stakeholders.
Executive Summary: The report provides overview of the key findings, market trends, and major insights of the Cancer Therapy and Testing market.
Market Overview: The report provides a comprehensive overview of the Cancer Therapy and Testing market, including its definition, historical development, and current market size. It covers market segmentation by Type (e.g., Cancer Detection, Cancer Treatment), region, and application, highlighting the key drivers, challenges, and opportunities within each segment.
Market Dynamics: The report analyses the market dynamics driving the growth and development of the Cancer Therapy and Testing market. The report includes an assessment of government policies and regulations, technological advancements, consumer trends and preferences, infrastructure development, and industry collaborations. This analysis helps stakeholders understand the factors influencing the Cancer Therapy and Testing market’s trajectory.
Competitive Landscape: The report provides an in-depth analysis of the competitive landscape within the Cancer Therapy and Testing market. It includes profiles of major market players, their market share, strategies, product portfolios, and recent developments.
Market Segmentation and Forecast: The report segment the Cancer Therapy and Testing market based on various parameters, such as by Type, region, and by Application. It provides market size and growth forecasts for each segment, supported by quantitative data and analysis. This helps stakeholders identify growth opportunities and make informed investment decisions.
Technological Trends: The report should highlight the key technological trends shaping the Cancer Therapy and Testing market, such as advancements in Type One technology and emerging substitutes. It analyses the impact of these trends on market growth, adoption rates, and consumer preferences.
Market Challenges and Opportunities: The report identify and analyses the major challenges faced by the Cancer Therapy and Testing market, such as technical bottleneck, cost limitations, and high entry barrier. It also highlights the opportunities for market growth, such as government incentives, emerging markets, and collaborations between stakeholders.
Regulatory and Policy Analysis: The report should assess the regulatory and policy landscape for Cancer Therapy and Testing, including government incentives, emission standards, and infrastructure development plans. It should analyse the impact of these policies on market growth and provide insights into future regulatory developments.
Recommendations and Conclusion: The report conclude with actionable recommendations for stakeholders, such as Application One Consumer, policymakers, investors, and infrastructure providers. These recommendations should be based on the research findings and address key challenges and opportunities within the Cancer Therapy and Testing market.
Supporting Data and Appendices: The report include supporting data, charts, and graphs to substantiate the analysis and findings. It also includes appendices with additional detailed information, such as data sources, survey questionnaires, and detailed market forecasts.
Market Segmentation
Cancer Therapy and Testing market is split by Type and by Application. For the period 2018-2029, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of value.
Market segment by Type
Cancer Detection
Cancer Treatment
Market segment by Application
Lung Cancer
Rectal Cancer
Breast Cancer
Other
Global Cancer Therapy and Testing Market Segment Percentages, By Region and Country, 2022 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Major players covered
Invitae
Foundation Medicine
Guardant Health
Illumina
Sysmex
Abingdon Health
Sophia
NanoEntek
BGI
Diagnosis
Exact Sciences
AstraZeneca
Bayer AG
Johnson & Johnson
Pfizer Inc.
Outline of Major Chapters:
Chapter 1: Introduces the definition of Cancer Therapy and Testing, market overview.
Chapter 2: Global Cancer Therapy and Testing market size in revenue.
Chapter 3: Detailed analysis of Cancer Therapy and Testing company competitive landscape, revenue and market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales of Cancer Therapy and Testing in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 8: The main points and conclusions of the report.

*** レポート目次（コンテンツ）***

1 Introduction to Research & Analysis Reports
1.1 Cancer Therapy and Testing Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Application
1.3 Global Cancer Therapy and Testing Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 Global Cancer Therapy and Testing Overall Market Size
2.1 Global Cancer Therapy and Testing Market Size: 2022 VS 2029
2.2 Global Cancer Therapy and Testing Market Size, Prospects & Forecasts: 2018-2029
2.3 Key Market Trends, Opportunity, Drivers and Restraints
2.3.1 Market Opportunities & Trends
2.3.2 Market Drivers
2.3.3 Market Restraints
3 Company Landscape
3.1 Top Cancer Therapy and Testing Players in Global Market
3.2 Top Global Cancer Therapy and Testing Companies Ranked by Revenue
3.3 Global Cancer Therapy and Testing Revenue by Companies
3.4 Top 3 and Top 5 Cancer Therapy and Testing Companies in Global Market, by Revenue in 2022
3.5 Global Companies Cancer Therapy and Testing Product Type
3.6 Tier 1, Tier 2 and Tier 3 Cancer Therapy and Testing Players in Global Market
3.6.1 List of Global Tier 1 Cancer Therapy and Testing Companies
3.6.2 List of Global Tier 2 and Tier 3 Cancer Therapy and Testing Companies
4 Market Sights by Product
4.1 Overview
4.1.1 By Type – Global Cancer Therapy and Testing Market Size Markets, 2022 & 2029
4.1.2 Cancer Detection
4.1.3 Cancer Treatment
4.2 By Type – Global Cancer Therapy and Testing Revenue & Forecasts
4.2.1 By Type – Global Cancer Therapy and Testing Revenue, 2018-2023
4.2.2 By Type – Global Cancer Therapy and Testing Revenue, 2024-2029
4.2.3 By Type – Global Cancer Therapy and Testing Revenue Market Share, 2018-2029
5 Sights by Application
5.1 Overview
5.1.1 By Application – Global Cancer Therapy and Testing Market Size, 2022 & 2029
5.1.2 Lung Cancer
5.1.3 Rectal Cancer
5.1.4 Breast Cancer
5.1.5 Other
5.2 By Application – Global Cancer Therapy and Testing Revenue & Forecasts
5.2.1 By Application – Global Cancer Therapy and Testing Revenue, 2018-2023
5.2.2 By Application – Global Cancer Therapy and Testing Revenue, 2024-2029
5.2.3 By Application – Global Cancer Therapy and Testing Revenue Market Share, 2018-2029
6 Sights by Region
6.1 By Region – Global Cancer Therapy and Testing Market Size, 2022 & 2029
6.2 By Region – Global Cancer Therapy and Testing Revenue & Forecasts
6.2.1 By Region – Global Cancer Therapy and Testing Revenue, 2018-2023
6.2.2 By Region – Global Cancer Therapy and Testing Revenue, 2024-2029
6.2.3 By Region – Global Cancer Therapy and Testing Revenue Market Share, 2018-2029
6.3 North America
6.3.1 By Country – North America Cancer Therapy and Testing Revenue, 2018-2029
6.3.2 US Cancer Therapy and Testing Market Size, 2018-2029
6.3.3 Canada Cancer Therapy and Testing Market Size, 2018-2029
6.3.4 Mexico Cancer Therapy and Testing Market Size, 2018-2029
6.4 Europe
6.4.1 By Country – Europe Cancer Therapy and Testing Revenue, 2018-2029
6.4.2 Germany Cancer Therapy and Testing Market Size, 2018-2029
6.4.3 France Cancer Therapy and Testing Market Size, 2018-2029
6.4.4 U.K. Cancer Therapy and Testing Market Size, 2018-2029
6.4.5 Italy Cancer Therapy and Testing Market Size, 2018-2029
6.4.6 Russia Cancer Therapy and Testing Market Size, 2018-2029
6.4.7 Nordic Countries Cancer Therapy and Testing Market Size, 2018-2029
6.4.8 Benelux Cancer Therapy and Testing Market Size, 2018-2029
6.5 Asia
6.5.1 By Region – Asia Cancer Therapy and Testing Revenue, 2018-2029
6.5.2 China Cancer Therapy and Testing Market Size, 2018-2029
6.5.3 Japan Cancer Therapy and Testing Market Size, 2018-2029
6.5.4 South Korea Cancer Therapy and Testing Market Size, 2018-2029
6.5.5 Southeast Asia Cancer Therapy and Testing Market Size, 2018-2029
6.5.6 India Cancer Therapy and Testing Market Size, 2018-2029
6.6 South America
6.6.1 By Country – South America Cancer Therapy and Testing Revenue, 2018-2029
6.6.2 Brazil Cancer Therapy and Testing Market Size, 2018-2029
6.6.3 Argentina Cancer Therapy and Testing Market Size, 2018-2029
6.7 Middle East & Africa
6.7.1 By Country – Middle East & Africa Cancer Therapy and Testing Revenue, 2018-2029
6.7.2 Turkey Cancer Therapy and Testing Market Size, 2018-2029
6.7.3 Israel Cancer Therapy and Testing Market Size, 2018-2029
6.7.4 Saudi Arabia Cancer Therapy and Testing Market Size, 2018-2029
6.7.5 UAE Cancer Therapy and Testing Market Size, 2018-2029
7 Cancer Therapy and Testing Companies Profiles
7.1 Invitae
7.1.1 Invitae Company Summary
7.1.2 Invitae Business Overview
7.1.3 Invitae Cancer Therapy and Testing Major Product Offerings
7.1.4 Invitae Cancer Therapy and Testing Revenue in Global Market (2018-2023)
7.1.5 Invitae Key News & Latest Developments
7.2 Foundation Medicine
7.2.1 Foundation Medicine Company Summary
7.2.2 Foundation Medicine Business Overview
7.2.3 Foundation Medicine Cancer Therapy and Testing Major Product Offerings
7.2.4 Foundation Medicine Cancer Therapy and Testing Revenue in Global Market (2018-2023)
7.2.5 Foundation Medicine Key News & Latest Developments
7.3 Guardant Health
7.3.1 Guardant Health Company Summary
7.3.2 Guardant Health Business Overview
7.3.3 Guardant Health Cancer Therapy and Testing Major Product Offerings
7.3.4 Guardant Health Cancer Therapy and Testing Revenue in Global Market (2018-2023)
7.3.5 Guardant Health Key News & Latest Developments
7.4 Illumina
7.4.1 Illumina Company Summary
7.4.2 Illumina Business Overview
7.4.3 Illumina Cancer Therapy and Testing Major Product Offerings
7.4.4 Illumina Cancer Therapy and Testing Revenue in Global Market (2018-2023)
7.4.5 Illumina Key News & Latest Developments
7.5 Sysmex
7.5.1 Sysmex Company Summary
7.5.2 Sysmex Business Overview
7.5.3 Sysmex Cancer Therapy and Testing Major Product Offerings
7.5.4 Sysmex Cancer Therapy and Testing Revenue in Global Market (2018-2023)
7.5.5 Sysmex Key News & Latest Developments
7.6 Abingdon Health
7.6.1 Abingdon Health Company Summary
7.6.2 Abingdon Health Business Overview
7.6.3 Abingdon Health Cancer Therapy and Testing Major Product Offerings
7.6.4 Abingdon Health Cancer Therapy and Testing Revenue in Global Market (2018-2023)
7.6.5 Abingdon Health Key News & Latest Developments
7.7 Sophia
7.7.1 Sophia Company Summary
7.7.2 Sophia Business Overview
7.7.3 Sophia Cancer Therapy and Testing Major Product Offerings
7.7.4 Sophia Cancer Therapy and Testing Revenue in Global Market (2018-2023)
7.7.5 Sophia Key News & Latest Developments
7.8 NanoEntek
7.8.1 NanoEntek Company Summary
7.8.2 NanoEntek Business Overview
7.8.3 NanoEntek Cancer Therapy and Testing Major Product Offerings
7.8.4 NanoEntek Cancer Therapy and Testing Revenue in Global Market (2018-2023)
7.8.5 NanoEntek Key News & Latest Developments
7.9 BGI
7.9.1 BGI Company Summary
7.9.2 BGI Business Overview
7.9.3 BGI Cancer Therapy and Testing Major Product Offerings
7.9.4 BGI Cancer Therapy and Testing Revenue in Global Market (2018-2023)
7.9.5 BGI Key News & Latest Developments
7.10 Diagnosis
7.10.1 Diagnosis Company Summary
7.10.2 Diagnosis Business Overview
7.10.3 Diagnosis Cancer Therapy and Testing Major Product Offerings
7.10.4 Diagnosis Cancer Therapy and Testing Revenue in Global Market (2018-2023)
7.10.5 Diagnosis Key News & Latest Developments
7.11 Exact Sciences
7.11.1 Exact Sciences Company Summary
7.11.2 Exact Sciences Business Overview
7.11.3 Exact Sciences Cancer Therapy and Testing Major Product Offerings
7.11.4 Exact Sciences Cancer Therapy and Testing Revenue in Global Market (2018-2023)
7.11.5 Exact Sciences Key News & Latest Developments
7.12 AstraZeneca
7.12.1 AstraZeneca Company Summary
7.12.2 AstraZeneca Business Overview
7.12.3 AstraZeneca Cancer Therapy and Testing Major Product Offerings
7.12.4 AstraZeneca Cancer Therapy and Testing Revenue in Global Market (2018-2023)
7.12.5 AstraZeneca Key News & Latest Developments
7.13 Bayer AG
7.13.1 Bayer AG Company Summary
7.13.2 Bayer AG Business Overview
7.13.3 Bayer AG Cancer Therapy and Testing Major Product Offerings
7.13.4 Bayer AG Cancer Therapy and Testing Revenue in Global Market (2018-2023)
7.13.5 Bayer AG Key News & Latest Developments
7.14 Johnson & Johnson
7.14.1 Johnson & Johnson Company Summary
7.14.2 Johnson & Johnson Business Overview
7.14.3 Johnson & Johnson Cancer Therapy and Testing Major Product Offerings
7.14.4 Johnson & Johnson Cancer Therapy and Testing Revenue in Global Market (2018-2023)
7.14.5 Johnson & Johnson Key News & Latest Developments
7.15 Pfizer Inc.
7.15.1 Pfizer Inc. Company Summary
7.15.2 Pfizer Inc. Business Overview
7.15.3 Pfizer Inc. Cancer Therapy and Testing Major Product Offerings
7.15.4 Pfizer Inc. Cancer Therapy and Testing Revenue in Global Market (2018-2023)
7.15.5 Pfizer Inc. Key News & Latest Developments
8 Conclusion
9 Appendix
9.1 Note
9.2 Examples of Clients
9.3 Disclaimer

List of Tables
Table 1. Cancer Therapy and Testing Market Opportunities & Trends in Global Market
Table 2. Cancer Therapy and Testing Market Drivers in Global Market
Table 3. Cancer Therapy and Testing Market Restraints in Global Market
Table 4. Key Players of Cancer Therapy and Testing in Global Market
Table 5. Top Cancer Therapy and Testing Players in Global Market, Ranking by Revenue (2022)
Table 6. Global Cancer Therapy and Testing Revenue by Companies, (US$, Mn), 2018-2023
Table 7. Global Cancer Therapy and Testing Revenue Share by Companies, 2018-2023
Table 8. Global Companies Cancer Therapy and Testing Product Type
Table 9. List of Global Tier 1 Cancer Therapy and Testing Companies, Revenue (US$, Mn) in 2022 and Market Share
Table 10. List of Global Tier 2 and Tier 3 Cancer Therapy and Testing Companies, Revenue (US$, Mn) in 2022 and Market Share
Table 11. By Type – Global Cancer Therapy and Testing Revenue, (US$, Mn), 2022 & 2029
Table 12. By Type - Cancer Therapy and Testing Revenue in Global (US$, Mn), 2018-2023
Table 13. By Type - Cancer Therapy and Testing Revenue in Global (US$, Mn), 2024-2029
Table 14. By Application – Global Cancer Therapy and Testing Revenue, (US$, Mn), 2022 & 2029
Table 15. By Application - Cancer Therapy and Testing Revenue in Global (US$, Mn), 2018-2023
Table 16. By Application - Cancer Therapy and Testing Revenue in Global (US$, Mn), 2024-2029
Table 17. By Region – Global Cancer Therapy and Testing Revenue, (US$, Mn), 2022 & 2029
Table 18. By Region - Global Cancer Therapy and Testing Revenue (US$, Mn), 2018-2023
Table 19. By Region - Global Cancer Therapy and Testing Revenue (US$, Mn), 2024-2029
Table 20. By Country - North America Cancer Therapy and Testing Revenue, (US$, Mn), 2018-2023
Table 21. By Country - North America Cancer Therapy and Testing Revenue, (US$, Mn), 2024-2029
Table 22. By Country - Europe Cancer Therapy and Testing Revenue, (US$, Mn), 2018-2023
Table 23. By Country - Europe Cancer Therapy and Testing Revenue, (US$, Mn), 2024-2029
Table 24. By Region - Asia Cancer Therapy and Testing Revenue, (US$, Mn), 2018-2023
Table 25. By Region - Asia Cancer Therapy and Testing Revenue, (US$, Mn), 2024-2029
Table 26. By Country - South America Cancer Therapy and Testing Revenue, (US$, Mn), 2018-2023
Table 27. By Country - South America Cancer Therapy and Testing Revenue, (US$, Mn), 2024-2029
Table 28. By Country - Middle East & Africa Cancer Therapy and Testing Revenue, (US$, Mn), 2018-2023
Table 29. By Country - Middle East & Africa Cancer Therapy and Testing Revenue, (US$, Mn), 2024-2029
Table 30. Invitae Company Summary
Table 31. Invitae Cancer Therapy and Testing Product Offerings
Table 32. Invitae Cancer Therapy and Testing Revenue (US$, Mn) & (2018-2023)
Table 33. Invitae Key News & Latest Developments
Table 34. Foundation Medicine Company Summary
Table 35. Foundation Medicine Cancer Therapy and Testing Product Offerings
Table 36. Foundation Medicine Cancer Therapy and Testing Revenue (US$, Mn) & (2018-2023)
Table 37. Foundation Medicine Key News & Latest Developments
Table 38. Guardant Health Company Summary
Table 39. Guardant Health Cancer Therapy and Testing Product Offerings
Table 40. Guardant Health Cancer Therapy and Testing Revenue (US$, Mn) & (2018-2023)
Table 41. Guardant Health Key News & Latest Developments
Table 42. Illumina Company Summary
Table 43. Illumina Cancer Therapy and Testing Product Offerings
Table 44. Illumina Cancer Therapy and Testing Revenue (US$, Mn) & (2018-2023)
Table 45. Illumina Key News & Latest Developments
Table 46. Sysmex Company Summary
Table 47. Sysmex Cancer Therapy and Testing Product Offerings
Table 48. Sysmex Cancer Therapy and Testing Revenue (US$, Mn) & (2018-2023)
Table 49. Sysmex Key News & Latest Developments
Table 50. Abingdon Health Company Summary
Table 51. Abingdon Health Cancer Therapy and Testing Product Offerings
Table 52. Abingdon Health Cancer Therapy and Testing Revenue (US$, Mn) & (2018-2023)
Table 53. Abingdon Health Key News & Latest Developments
Table 54. Sophia Company Summary
Table 55. Sophia Cancer Therapy and Testing Product Offerings
Table 56. Sophia Cancer Therapy and Testing Revenue (US$, Mn) & (2018-2023)
Table 57. Sophia Key News & Latest Developments
Table 58. NanoEntek Company Summary
Table 59. NanoEntek Cancer Therapy and Testing Product Offerings
Table 60. NanoEntek Cancer Therapy and Testing Revenue (US$, Mn) & (2018-2023)
Table 61. NanoEntek Key News & Latest Developments
Table 62. BGI Company Summary
Table 63. BGI Cancer Therapy and Testing Product Offerings
Table 64. BGI Cancer Therapy and Testing Revenue (US$, Mn) & (2018-2023)
Table 65. BGI Key News & Latest Developments
Table 66. Diagnosis Company Summary
Table 67. Diagnosis Cancer Therapy and Testing Product Offerings
Table 68. Diagnosis Cancer Therapy and Testing Revenue (US$, Mn) & (2018-2023)
Table 69. Diagnosis Key News & Latest Developments
Table 70. Exact Sciences Company Summary
Table 71. Exact Sciences Cancer Therapy and Testing Product Offerings
Table 72. Exact Sciences Cancer Therapy and Testing Revenue (US$, Mn) & (2018-2023)
Table 73. Exact Sciences Key News & Latest Developments
Table 74. AstraZeneca Company Summary
Table 75. AstraZeneca Cancer Therapy and Testing Product Offerings
Table 76. AstraZeneca Cancer Therapy and Testing Revenue (US$, Mn) & (2018-2023)
Table 77. AstraZeneca Key News & Latest Developments
Table 78. Bayer AG Company Summary
Table 79. Bayer AG Cancer Therapy and Testing Product Offerings
Table 80. Bayer AG Cancer Therapy and Testing Revenue (US$, Mn) & (2018-2023)
Table 81. Bayer AG Key News & Latest Developments
Table 82. Johnson & Johnson Company Summary
Table 83. Johnson & Johnson Cancer Therapy and Testing Product Offerings
Table 84. Johnson & Johnson Cancer Therapy and Testing Revenue (US$, Mn) & (2018-2023)
Table 85. Johnson & Johnson Key News & Latest Developments
Table 86. Pfizer Inc. Company Summary
Table 87. Pfizer Inc. Cancer Therapy and Testing Product Offerings
Table 88. Pfizer Inc. Cancer Therapy and Testing Revenue (US$, Mn) & (2018-2023)
Table 89. Pfizer Inc. Key News & Latest Developments
List of Figures
Figure 1. Cancer Therapy and Testing Segment by Type in 2022
Figure 2. Cancer Therapy and Testing Segment by Application in 2022
Figure 3. Global Cancer Therapy and Testing Market Overview: 2022
Figure 4. Key Caveats
Figure 5. Global Cancer Therapy and Testing Market Size: 2022 VS 2029 (US$, Mn)
Figure 6. Global Cancer Therapy and Testing Revenue, 2018-2029 (US$, Mn)
Figure 7. The Top 3 and 5 Players Market Share by Cancer Therapy and Testing Revenue in 2022
Figure 8. By Type - Global Cancer Therapy and Testing Revenue Market Share, 2018-2029
Figure 9. By Application - Global Cancer Therapy and Testing Revenue Market Share, 2018-2029
Figure 10. By Type - Global Cancer Therapy and Testing Revenue, (US$, Mn), 2022 & 2029
Figure 11. By Type - Global Cancer Therapy and Testing Revenue Market Share, 2018-2029
Figure 12. By Application - Global Cancer Therapy and Testing Revenue, (US$, Mn), 2022 & 2029
Figure 13. By Application - Global Cancer Therapy and Testing Revenue Market Share, 2018-2029
Figure 14. By Region - Global Cancer Therapy and Testing Revenue Market Share, 2018-2029
Figure 15. By Country - North America Cancer Therapy and Testing Revenue Market Share, 2018-2029
Figure 16. US Cancer Therapy and Testing Revenue, (US$, Mn), 2018-2029
Figure 17. Canada Cancer Therapy and Testing Revenue, (US$, Mn), 2018-2029
Figure 18. Mexico Cancer Therapy and Testing Revenue, (US$, Mn), 2018-2029
Figure 19. By Country - Europe Cancer Therapy and Testing Revenue Market Share, 2018-2029
Figure 20. Germany Cancer Therapy and Testing Revenue, (US$, Mn), 2018-2029
Figure 21. France Cancer Therapy and Testing Revenue, (US$, Mn), 2018-2029
Figure 22. U.K. Cancer Therapy and Testing Revenue, (US$, Mn), 2018-2029
Figure 23. Italy Cancer Therapy and Testing Revenue, (US$, Mn), 2018-2029
Figure 24. Russia Cancer Therapy and Testing Revenue, (US$, Mn), 2018-2029
Figure 25. Nordic Countries Cancer Therapy and Testing Revenue, (US$, Mn), 2018-2029
Figure 26. Benelux Cancer Therapy and Testing Revenue, (US$, Mn), 2018-2029
Figure 27. By Region - Asia Cancer Therapy and Testing Revenue Market Share, 2018-2029
Figure 28. China Cancer Therapy and Testing Revenue, (US$, Mn), 2018-2029
Figure 29. Japan Cancer Therapy and Testing Revenue, (US$, Mn), 2018-2029
Figure 30. South Korea Cancer Therapy and Testing Revenue, (US$, Mn), 2018-2029
Figure 31. Southeast Asia Cancer Therapy and Testing Revenue, (US$, Mn), 2018-2029
Figure 32. India Cancer Therapy and Testing Revenue, (US$, Mn), 2018-2029
Figure 33. By Country - South America Cancer Therapy and Testing Revenue Market Share, 2018-2029
Figure 34. Brazil Cancer Therapy and Testing Revenue, (US$, Mn), 2018-2029
Figure 35. Argentina Cancer Therapy and Testing Revenue, (US$, Mn), 2018-2029
Figure 36. By Country - Middle East & Africa Cancer Therapy and Testing Revenue Market Share, 2018-2029
Figure 37. Turkey Cancer Therapy and Testing Revenue, (US$, Mn), 2018-2029
Figure 38. Israel Cancer Therapy and Testing Revenue, (US$, Mn), 2018-2029
Figure 39. Saudi Arabia Cancer Therapy and Testing Revenue, (US$, Mn), 2018-2029
Figure 40. UAE Cancer Therapy and Testing Revenue, (US$, Mn), 2018-2029
Figure 41. Invitae Cancer Therapy and Testing Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 42. Foundation Medicine Cancer Therapy and Testing Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 43. Guardant Health Cancer Therapy and Testing Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 44. Illumina Cancer Therapy and Testing Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 45. Sysmex Cancer Therapy and Testing Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 46. Abingdon Health Cancer Therapy and Testing Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 47. Sophia Cancer Therapy and Testing Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 48. NanoEntek Cancer Therapy and Testing Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 49. BGI Cancer Therapy and Testing Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 50. Diagnosis Cancer Therapy and Testing Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 51. Exact Sciences Cancer Therapy and Testing Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 52. AstraZeneca Cancer Therapy and Testing Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 53. Bayer AG Cancer Therapy and Testing Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 54. Johnson & Johnson Cancer Therapy and Testing Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 55. Pfizer Inc. Cancer Therapy and Testing Revenue Year Over Year Growth (US$, Mn) & (2018-2023)



*** 免責事項 ***
https://www.globalresearch.co.jp/disclaimer/
※関連調査資料
  • 膀胱がん標的療法のグローバル市場展望 2023年-2029年：アテゾリズマブ（テセントリク）、アベルマブ（バベンシオ）、エルダフィチニブ（バルバーサ）、その他
  • 乳がんホルモン療法のグローバル市場展望 2023年-2029年：アロマターゼ阻害剤、選択的エストロゲン受容体調節剤、その他
  • 標的癌治療のグローバル市場展望 2023年-2029年：キナーゼ阻害剤、モノクローナル抗体、PARP阻害剤、その他
  • 脳腫瘍標的療法のグローバル市場展望 2023年-2029年：ベルズティファン（ウェリレグ）、ベバシズマブ（アバスチン）、エベロリムス（アフィニトール）
  • がん最小残存病変検査のグローバル市場展望 2023年-2029年：フローサイトメトリー、ポリメラーゼ連鎖反応（PCR）、次世代シーケンシング（NGS）、その他
    • ※注目の調査資料
     ※当サイト上のレポートデータは弊社H&Iグローバルリサーチ運営のMarketReport.jpサイトと連動しています。
    ※当市場調査資料(MMG23DC12280 )"がん治療&検査装置のグローバル市場展望 2023年-2029年：がん検出、がん治療" (英文：Cancer Therapy and Testing Market, Global Outlook and Forecast 2023-2029)はMarket Monitor Global社が調査・発行しており、H&Iグローバルリサーチが販売します。

    ◆H&Iグローバルリサーチのお客様（例）◆


    ※当サイトに掲載していない調査資料も弊社を通してご購入可能ですので、お気軽にご連絡ください。ウェブサイトでは紹介しきれない資料も数多くございます。
    ※無料翻訳ツールをご利用いただけます。翻訳可能なPDF納品ファイルが対象です。ご利用を希望されるお客様はご注文の時にその旨をお申し出ください。